Skip to main content
logo
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
22.75
+0.12 (0.53%)
At close: Jan 21, 2026, 4:00 PM EST
22.30
-0.45 (-1.98%)
After-hours: Jan 21, 2026, 7:41 PM EST

Ultragenyx Pharmaceutical Revenue by Segment

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Product
339.18M321.49M314.47M285.47M265.30M230.30M198.70M180.40M
Product Growth
27.85%39.59%58.26%58.24%68.34%55.82%45.67%51.72%
Other
291.43M288.69M276.21M274.71M257.40M250.90M243.80M253.80M
Other Growth
13.22%15.06%13.29%8.24%1.90%2.37%2.65%8.28%

Revenue by Geography

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
North America
361.22M354.58M340.56M340.46M316.40M307.30M297.70M307.10M
North America Growth
14.16%15.39%14.40%10.86%5.82%3.05%4.02%9.29%
Latin America
149.83M144.47M150.40M130.71M130.30M109.50M89.70M77.30M
Latin America Growth
14.99%31.93%67.67%69.10%93.32%70.30%55.46%72.93%
Europe
103.33M97.65M87.45M80.12M69.60M60.40M54.20M47.60M
Europe Growth
48.47%61.68%61.35%68.33%63.00%58.53%44.15%30.77%
Japan
14.94M12.89M9.69M-7.60M6.50M---------------
Japan Growth
129.83%--------------------
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.